Literature DB >> 24293815

The Distribution of CCR2-64I, SDF1-3'A and MCP1-2518 G/A Genes Polymorphism in a Specific High Risk Group from the Northeastern States West Bengal, and Gorkha Population in India.

Partha Roy1, Sekhar Chakrabarti.   

Abstract

We studied the prevalence and effects of host genetic polymorphisms for the three AIDS restriction genes (ARGs) namely CCR2-64I, SDF1-3'A and MCP1-2518 G/A for HIV infection and progression to AIDS using PCR-RFLP analysis on a total of 568 HIV seronegative serum samples collected from a specific high risk and young population hailing from the seven Northeastern states of India (n = 346), West Bengal (n = 96) and Gorkha population (n = 101). In addition, 181 HIV seropositive cases of which 92 inpatient cases in a large tertiary care hospital located at Kolkata were included in the study. HIV prevalence in our study group was 0.52 %. Four cases seroconverted, 25 cases progressed to AIDS and 05 died during the follow up period of 41 months. The genotype percentage of CCR2-64I, SDF1-3'A and MCP1-2518 G/A in the Northeastern states were 18.5, 40.3 and 54 % respectively in the seronegative population. Allele frequencies for SDF1-3'A in Northeastern states were significantly higher as compared to the Gorkha (21 %) and the North Indian population (24 %). Relative Hazard values were more than 0.9 for progression to AIDS and death. Kaplan-Meier survival analysis using Cox proportional regression model did not reveal any significant survival benefit (p value <0.05) for any of the 3 ARGs individually or in combination either to seroconversion or disease progression. This is the first study on host genetic polymorphism amongst the Eastern, Northeastern and Gorkha regions in India. We are also the first to report the MCP1-2518 G/A polymorphism in India that is known to increase the rate of neuropsychological impairment (NPI) in AIDS patients.

Entities:  

Keywords:  AIDS restriction genes (ARG’s); CCR2-64I; Gorkha; Host gene polymorphism; MCP1-2518 G/A; Northeastern states (NES); SDF1-3′A; West Bengal

Year:  2012        PMID: 24293815      PMCID: PMC3550781          DOI: 10.1007/s13337-012-0092-1

Source DB:  PubMed          Journal:  Indian J Virol        ISSN: 0970-2822


  27 in total

1.  Phylogenetic analysis of env, gag, and tat genes of HIV type 1 detected among the injecting drug users in West Bengal, India.

Authors:  Ranajoy Mullick; Satarupa Sengupta; Kamalesh Sarkar; M K Saha; Sekhar Chakrabarti
Journal:  AIDS Res Hum Retroviruses       Date:  2006-12       Impact factor: 2.205

2.  Epidemic of HIV coupled with hepatitis C virus among injecting drug users of Himalayan West Bengal, Eastern India, Bordering Nepal, Bhutan, and Bangladesh.

Authors:  Kamalesh Sarkar; Baishali Bal; Rita Mukherjee; Sekhar Chakraborty; Swapan Kumar Niyogi; Malay Kumar Saha; Sujit Kumar Bhattacharya
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

3.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

Authors:  T Dragic; V Litwin; G P Allaway; S R Martin; Y Huang; K A Nagashima; C Cayanan; P J Maddon; R A Koup; J P Moore; W A Paxton
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

4.  Mutational analysis of the CCR5 and CXCR4 genes (HIV-1 co-receptors) in resistance to HIV-1 infection and AIDS development among intravenous drug users.

Authors:  V Alvarez; C López-Larrea; E Coto
Journal:  Hum Genet       Date:  1998-04       Impact factor: 4.132

5.  Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.

Authors:  Romsha Verma; Radha Ballabh Gupta; Kalpana Singh; Rama Bhasin; Abhay Anand Shukla; Shyam S Chauhan; Kalpana Luthra
Journal:  J Clin Virol       Date:  2007-01-19       Impact factor: 3.168

6.  Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals.

Authors:  J Eugen-Olsen; A K Iversen; P Garred; U Koppelhus; C Pedersen; T L Benfield; A M Sorensen; T Katzenstein; E Dickmeiss; J Gerstoft; P Skinhøj; A Svejgaard; J O Nielsen; B Hofmann
Journal:  AIDS       Date:  1997-03       Impact factor: 4.177

7.  Distribution of three HIV-1 resistance-conferring polymorphisms (SDF1-3'A, CCR2-641, and CCR5-delta32) in global populations.

Authors:  B Su; G Sun; D Lu; J Xiao; F Hu; R Chakraborty; R Deka; L Jin
Journal:  Eur J Hum Genet       Date:  2000-12       Impact factor: 4.246

8.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

9.  Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants.

Authors:  R P van Rij; A M de Roda Husman; M Brouwer; J Goudsmit; R A Coutinho; H Schuitemaker
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

10.  Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression.

Authors:  S Mummidi; S S Ahuja; E Gonzalez; S A Anderson; E N Santiago; K T Stephan; F E Craig; P O'Connell; V Tryon; R A Clark; M J Dolan; S K Ahuja
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.